Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Portuguese single center experience in balloon pulmonary angioplasty: haemodynamics and clinical short-term effects
Session:
Posters 3 - Écran 3 - Circulação / Embolia Pulmonar
Speaker:
Daniel Sebaiti
Congress:
CPC 2019
Topic:
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
Theme:
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
Subtheme:
21.4 Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure - Treatment
Session Type:
Posters
FP Number:
---
Authors:
Daniel Sebaiti; Filipa Ferreira; Rita Calé; Maria José Loureiro; Sofia Alegria; Silvia Vitorino; Pedro; Débora Repolho; Gonçalo Jácome Morgado; Helder Pereira
Abstract
<p>Aims: In patients with chronic thromboembolic pulmonary hypertension (CTEPH) refused for pulmonary endarterectomy, the only treatment available in Portugal until recently, was pulmonary vasodilator therapy (PVT). Our aim is to evaluate the immediate efficacy of balloon pulmonary angioplasty (BPA) beyond PVT in patients with non-operable CTEPH or residual and recurrent pulmonary hypertension (PH) after pulmonary endarterectomy.</p> <p>Methods and Results:</p> <p>From December 2017 to December 2018, we performed a total of 57 procedures in 12 patients. Haemodynamics, NT-proBNP and World Health Organization (WHO) functional class were evaluated at the diagnosis, before the 1<sup>st</sup> session and in the last session of BPA in 7 consecutive CTEPH patients (mean age 66±11, 57% female) who completed the BPA treatment (median of 5 sessions per patient, 3,5±1,7 vessels dilated per session, 9,9±1,3 segments treated in all procedures). The median duration between CTEPH diagnosis and first BPA was 55 months and from first to last BPA was 4 months. After PVT, patients showed improvement of mean pulmonary arterial pressure and pulmonary vascular resistance (figure 1). After BPA there was a significant additional improvement of mean PAP (p=0,026), a slightly decreased pulmonary vascular resistance (PVR) and increased cardiac index. BPA showed a trend to improvement of NT-proBNP (p=0,091). At CTEPH diagnosis and after PVT patient were symptomatic (WHO functional class II, III, IV: 4/2/1 and 6/1/0, respectively) and after BPA 86% improved to WHO class I. In these 7 CTEPH patients, 2 had mild pulmonary reperfusion edema without the need of invasive ventilation There was no peri-procedural death.</p> <p>Conclusion:</p> <p>BPA further improves short term haemodynamics and functional class in patients with non-operable CTEPH or residual/recurrent PH on vasodilator therapy</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site